Literature DB >> 27649984

[Aphasia: evidence-based therapy approaches].

R Darkow1, A Flöel2.   

Abstract

Speech and language therapy is essential in the rehabilitation of aphasic disorders following a stroke. Due to the predicted increase of aphasia and limited resources within the healthcare system, the development of efficient and sustainable treatment methods is of exceptional importance. The effectiveness of both traditional and innovative approaches needs to be evaluated against the standards of evidence-based medicine. Class I evidence has been established for high-intensity speech and language therapy in subacute and chronic stages of aphasia. Innovative training-based approaches have so far only been evaluated in small studies but promising results have been shown for computer-based naming, video-based exercises for verbalization of complex contents and approaches modeled according to "forced-use" principles with standardized contents. Adjuvant training therapies are being developed to increase and prolong the impact of training alone, most notably non-invasive brain stimulation and pharmacological modulation. Transcranial direct current stimulation has been shown to effectively enhance training in several small randomized controlled trials but several questions still remain to be answered, including the location of electrode placement as well as the length and intensity of stimulation. Mixed evidence has been collected for the effectiveness of pharmacotherapy on speech learning and further randomized controlled trials are also needed to allow more firmly based recommendations.

Entities:  

Keywords:  Pharmacotherapy; Rehabilitation; Speech/language therapy; Stroke; Transcranial direct current stimulation

Mesh:

Year:  2016        PMID: 27649984     DOI: 10.1007/s00115-016-0213-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  23 in total

1.  L-dopa does not add to the success of high-intensity language training in aphasia.

Authors:  Caterina Breitenstein; Catharina Korsukewitz; Annette Baumgärtner; Agnes Flöel; Pienie Zwitserlood; Christian Dobel; Stefan Knecht
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

Review 2.  Pharmacological treatment for aphasia following stroke.

Authors:  J Greener; P Enderby; R Whurr
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Technique to improve chronic motor deficit after stroke.

Authors:  E Taub; N E Miller; T A Novack; E W Cook; W C Fleming; C S Nepomuceno; J S Connell; J E Crago
Journal:  Arch Phys Med Rehabil       Date:  1993-04       Impact factor: 3.966

4.  Piracetam in the treatment of acute stroke.

Authors:  J M Orgogozo
Journal:  Pharmacopsychiatry       Date:  1999-03       Impact factor: 5.788

5.  Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.

Authors:  J Kessler; A Thiel; H Karbe; W D Heiss
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

6.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

Authors:  François Chollet; Jean Tardy; Jean-François Albucher; Claire Thalamas; Emilie Berard; Catherine Lamy; Yannick Bejot; Sandrine Deltour; Assia Jaillard; Philippe Niclot; Benoit Guillon; Thierry Moulin; Philippe Marque; Jérémie Pariente; Catherine Arnaud; Isabelle Loubinoux
Journal:  Lancet Neurol       Date:  2011-01-07       Impact factor: 44.182

Review 7.  Drug treatment of poststroke aphasia.

Authors:  A M O Bakheit
Journal:  Expert Rev Neurother       Date:  2004-03       Impact factor: 4.618

Review 8.  tDCS-enhanced motor and cognitive function in neurological diseases.

Authors:  Agnes Flöel
Journal:  Neuroimage       Date:  2013-05-30       Impact factor: 6.556

Review 9.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

10.  FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.

Authors:  Annette Baumgaertner; Tanja Grewe; Wolfram Ziegler; Agnes Floel; Luise Springer; Peter Martus; Caterina Breitenstein
Journal:  Trials       Date:  2013-09-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.